1. Home
  2. VANI vs CANG Comparison

VANI vs CANG Comparison

Compare VANI & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

SELL

Current Price

$1.16

Market Cap

111.0M

Sector

Health Care

ML Signal

SELL

Logo Cango Inc.  each representing two (2)

CANG

Cango Inc. each representing two (2)

SELL

Current Price

$3.88

Market Cap

116.5M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
VANI
CANG
Founded
1998
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
116.5M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
VANI
CANG
Price
$1.16
$3.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$3.83
★ $6.25
AVG Volume (30 Days)
153.0K
★ 1.5M
Earning Date
11-12-2026
11-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$39.31
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.92
$0.17
52 Week High
$1.92
$4.51

Technical Indicators

Market Signals
Indicator
VANI
CANG
Relative Strength Index (RSI) 37.37 69.69
Support Level $1.15 $1.64
Resistance Level $1.25 $4.13
Average True Range (ATR) 0.04 0.41
MACD -0.00 0.09
Stochastic Oscillator 4.32 86.43

Price Performance

Historical Comparison
VANI
CANG

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About CANG Cango Inc. each representing two (2)

Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.

Share on Social Networks: